Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

Liu X., Shaw RH., Stuart ASV., Greenland M., Dinesh T., Provstgaard-Morys S., Clutterbuck E., Ramasamy MN., Aley PK., Farooq Mujadidi Y., Long F., Plested E., Robinson H., Singh N., Walker LL., White R., Andrews N., Cameron JC., Collins AM., Ferreira DM., Hill HC., Green CA., Hallis B., Heath PT., Faust SN., Finn A., Lambe T., Lazarus R., Libri V., Ramsay ME., Read RC., Turner DPJ., Turner PJ., Nguyen-Van-Tam JS., Snape MD., Group C-CS.

DOI

10.2139/ssrn.3874014

Type

Journal article

Journal

SSRN Electronic Journal

Publisher

Elsevier BV

Publication Date

29/06/2021

Permalink Original publication